U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced a bold plan to identify the cause of autism by September 2025. Speaking at a cabinet meeting with President Donald Trump, Kennedy declared a global research initiative involving hundreds of scientists to determine the source of rising autism rates, which reached 1 in 36 children by 2020, according to the CDC.
“We’ll know by September what has caused the autism epidemic and how to eliminate those exposures,” Kennedy said, hinting at environmental and artificial factors. The initiative is part of Trump’s broader “Make America Healthy Again” Commission, which is also reviewing rising childhood conditions like asthma and ADHD.
The autism community, however, responded with skepticism. Kristyn Roth of the Autism Society of America criticized the deadline and the framing of autism as an “epidemic,” warning it promotes fear and stigmatization. Experts caution that increased diagnoses are largely due to expanded diagnostic criteria and awareness, not an unknown epidemic.
Kennedy, known for promoting a disproven link between vaccines and autism, confirmed vaccines will be reviewed, along with potential environmental and lifestyle triggers. Meanwhile, a recent study has strengthened ties between prenatal diabetes and autism risk.
Controversy deepened after reports surfaced of David Geier—previously fined for unlicensed medical practices—being hired to investigate vaccine links. Lawmakers and advocacy groups fear the spread of misinformation under Kennedy’s leadership.
The National Institutes of Health and the CDC, both under Kennedy’s purview, are planning multimillion-dollar research efforts into autism causes, including vaccine-related studies. Critics argue the push may politicize science and mislead the public.
Despite widespread concern, Kennedy remains firm: “There will be no bigger news than finding the cause of autism.” Whether science can meet his deadline remains uncertain.


Tabletop particle accelerator could transform medicine and materials science
U.S. and El Salvador Sign Landmark Critical Minerals Agreement to Boost Investment and Trade
Neuralink Expands Brain Implant Trials with 12 Global Patients
FDA Pilot Program Eases Rules for Nicotine Pouch Makers
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
U.S. Approves Over $6.5 Billion in Military Sales to Israel Across Three Defense Contracts
Syria-Kurdish Ceasefire Marks Historic Step Toward National Unity
Faith Leaders Arrested on Capitol Hill During Protest Against Trump Immigration Policies and ICE Funding
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
SpaceX Starship Test Flight Reaches New Heights but Ends in Setback
CDC Vaccine Review Sparks Controversy Over Thimerosal Study Citation 



